Exploring the feasibility of sharing information on medicine prices across countries

Marjolijn Moens, Eliana Barrenho and Valérie Paris

No 171, OECD Health Working Papers from OECD Publishing

Abstract: In recent years, the call for transparency in pharmaceutical pricing has gained momentum among policymakers and stakeholders. Following a resolution of the 72nd World Health Assembly and the establishment of the Oslo Medicines Initiative, there has been a concerted push for greater transparency in pricing practices. However, the exact scope of transparency measures remains unclear. Key questions persist regarding which prices and for which medicines should be disclosed, the conditions under which countries are willing to share this information, and the barriers hindering such efforts. To clarify these issues and advance the policy debate, the OECD examined the feasibility of sharing medicine price information across countries. A country survey was conducted to explore the willingness, expectations, and motives of governments and payers for sharing information on medicine prices. This report presents the key findings derived from the survey and concludes with an assessment of the feasibility of sharing net medicine price information among OECD countries.

JEL-codes: F6 H51 H57 I11 I18 K12 K23 K32 L1 L65 (search for similar items in EconPapers)
Date: 2024-09-11
New Economics Papers: this item is included in nep-com and nep-reg
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1787/5e4a7a47-en (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oec:elsaad:171-en

Access Statistics for this paper

More papers in OECD Health Working Papers from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by ().